Erratum: Pertinence of glioma and single nucleotide polymorphism of TERT, CCDC26, CDKN2A/B, and RTEL1 genes in glioma: a meta-analysis

Erratum: Pertinence of glioma and single nucleotide polymorphism of TERT, CCDC26, CDKN2A/B, and RTEL1 genes in glioma: a meta-analysis

Bibliographic Details
Main Author:	Frontiers Production Office
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-03-01
Series:	Frontiers in Oncology
Subjects:	glioma single nucleotide polymorphism risk meta-analysis genetic model
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1393063/full

Similar Items

Pertinence of glioma and single nucleotide polymorphism of TERT, CCDC26, CDKN2A/B and RTEL1 genes in glioma: a meta-analysis
by: Yaqi Wu, et al.
Published: (2023-09-01)

Erratum: Hepcidin is upregulated and is a potential therapeutic target associated with immunity in glioma
by: Frontiers Production Office
Published: (2022-12-01)

Erratum: Neurological symptom improvement after re-irradiation in patients with diffuse intrinsic pontine glioma: A retrospective analysis of the SIOP-E-HGG/DIPG project
by: Frontiers Production Office
Published: (2023-03-01)

CCDC103 as a Prognostic Biomarker Correlated with Tumor Progression and Immune Infiltration in Glioma
by: Xu Z, et al.
Published: (2023-10-01)

High expression of RTEL1 predicates worse progression in gliomas and promotes tumorigenesis through JNK/ELK1 cascade
by: Guanjie Wang, et al.
Published: (2024-03-01)

Impact of TREM1 Variants on the Risk and Prognosis of Glioma in the Chinese Han Population
by: Hu M, et al.
Published: (2023-07-01)

Genetic variants in XPD gene and glioma susceptibility in Chinese children: A multicenter case–control study
by: Yong‐Ping Chen, et al.
Published: (2022-06-01)

MiR-484 promotes the malignant progression of glioma by inhibiting CDKN2A expression
by: Yingrui Gu, et al.
Published: (2023-08-01)

Pathophysiological roles of integrins in gliomas from the perspective of glioma stem cells
by: Maoyu Wang, et al.
Published: (2022-09-01)

IGFBP2 from a novel copper metabolism-associated biomarker promoted glioma progression and response to immunotherapy
by: Qisheng Luo, et al.
Published: (2023-10-01)

Nasal glioma
by: Vučković Nada, et al.
Published: (2006-01-01)

P16 immunohistochemistry is a sensitive and specific surrogate marker for CDKN2A homozygous deletion in gliomas
by: Meenakshi Vij, et al.
Published: (2023-05-01)

Glioma Immunotherapy: Advances and Challenges for Spinal Cord Gliomas
by: Clare Grady, et al.
Published: (2022-03-01)

Glioma Stem Cells in Pediatric High-Grade Gliomas: From Current Knowledge to Future Perspectives
by: Marc-Antoine Da-Veiga, et al.
Published: (2022-05-01)

Preclinical Models of Low-Grade Gliomas
by: Pushan Dasgupta, et al.
Published: (2023-01-01)

Advances in Research of Adult Gliomas
by: Alina Finch, et al.
Published: (2021-01-01)

Epithelial-mesenchymal transition is the main way in which glioma-associated microglia/macrophages promote glioma progression
by: Xin He, et al.
Published: (2023-03-01)

Pan-glioma analyses reveal species- and tumor-specific regulation of neuron-glioma synapse genes by lncRNAs
by: Wei Xiong, et al.
Published: (2023-08-01)

Expression of lncRNAs in glioma: A lighthouse for patients with glioma
by: Xiaolin Lu, et al.
Published: (2024-02-01)

Editorial: Surgical approaches for the treatment of glioma
by: G. La Rocca, et al.
Published: (2022-11-01)

Tumor Microenvironment in Glioma Invasion
by: Sho Tamai, et al.
Published: (2022-04-01)

High-grade gliomas [electronic resource]: diagnosis and treatment/
by: Barnett, Gene H. 244111, et al.
Published: (2007)

Angiocentric Glioma: The Infiltrative Glioma with Ependymal Differentiation
by: Ayca ERSEN, et al.
Published: (2017-09-01)

Genetics and epigenetics of gliomas
by: Mario Luca Suvà
Published: (2014-10-01)

Immunotherapy is expected to be the ultimate nemesis of malignant glioma
by: Xue⁃jun YANG
Published: (2020-02-01)

The pertinence of gastric cancer and interleukin 10–819 single nucleotide polymorphisms: a meta-analysis and systematic review
by: Qianqian Mao, et al.
Published: (2024-02-01)

Surgical Treatment of Paediatric Thalamic Gliomas—Single-Centre Experience
by: David Krahulik, et al.
Published: (2024-01-01)

Nasal Glioma: Case report
by: Ozgur Surmelioglu, et al.
Published: (2011-02-01)

Nasal Glioma: Case report
by: Ozgur Surmelioglu, et al.
Published: (2011-03-01)

Thrombospondin-2 promotes the proliferation and migration of glioma cells and contributes to the progression of glioma
by: Tian-Lan Huang, et al.
Published: (2022-12-01)

Bevacizumab in recurrent WHO grades II–III glioma
by: Soufyan Annakib, et al.
Published: (2023-07-01)

p16 Immunohistochemical Expression as a Surrogate Assessment of CDKN2A Alteration in Gliomas Leading to Prognostic Significances
by: Lucas Geyer, et al.
Published: (2023-02-01)

Factors Related to the Recurrence of Low-grade Gliomas
by: David Ilun Tseng Lin, et al.
Published: (2023-12-01)

Molecular Mechanisms and Clinical Challenges of Glioma Invasion
by: Tomoya Oishi, et al.
Published: (2022-02-01)

Microglia and macrophage metabolism: a regulator of cerebral gliomas
by: Yue Deng, et al.
Published: (2024-04-01)

CSF-Glioma: A Causal Segmentation Framework for Accurate Grading and Subregion Identification of Gliomas
by: Yao Zheng, et al.
Published: (2023-07-01)

Impact of <i>CDKN2A/B</i> Homozygous Deletion on the Prognosis and Biology of IDH-Mutant Glioma
by: L. Eric Huang
Published: (2022-01-01)

Autophagy as a Potential Therapy for Malignant Glioma
by: Angel Escamilla-Ramírez, et al.
Published: (2020-07-01)

Cadherin Expression and EMT: A Focus on Gliomas
by: Carolina Noronha, et al.
Published: (2021-09-01)

Novel diagnostic and therapeutic approaches to malignant glioma
by: Swiss Medical Weekly
Published: (2011-05-01)